Sustained Therapeutics
PrivateLast Round
Accelerator
Oct 1, 2020
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sustained Therapeutics operates in Healthcare & Life Sciences and is based in Vancouver, British Columbia. Its latest recorded funding round was an Accelerator round in October 2020.
Sustained Therapeutics is a pharmaceutical company that develops a patented sustained-release platform designed to deliver approved drugs for unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sustained Therapeutics Comparables
Compare Sustained Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InSitu Biologics, Inc. | 84% | |
| Allay Therapeutics | 83% | |
| Concentric Analgesics | 80% |
For institutional investors. Book with your work email.
Sustained Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sustained Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| UBC Investment Management | Accelerator |
| HATCH Venture Builder | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 166% MoM, reaching 3K.
- May 15, 2026
Monthly visitors increased 220% MoM.
For institutional investors. Book with your work email.
Sustained Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sustained Therapeutics's valuation, stock price, and market status.
Is Sustained Therapeutics a public or private company?
Sustained Therapeutics is a private company.
What is the current stock price of Sustained Therapeutics?
Sustained Therapeutics is a private company, so its shares have no public market price. Caplight tracks Sustained Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sustained Therapeutics worth (valuation)?
Valuation information for Sustained Therapeutics is not publicly available.
Can I buy Sustained Therapeutics stock?
Sustained Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sustained Therapeutics's last funding round?
Sustained Therapeutics's most recent funding round was Accelerator on October 1, 2020.
Who are the main investors in Sustained Therapeutics?
Key investors in Sustained Therapeutics include Creative Destruction Lab, UBC Investment Management, HATCH Venture Builder.
Will Sustained Therapeutics IPO soon?
No public IPO plans have been announced for Sustained Therapeutics.
How can I track Sustained Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Sustained Therapeutics's shares on secondary markets.